ICD-10-CM Code R75

Inconclusive laboratory evidence of human immunodeficiency virus [HIV]

Version 2020 Billable Code No Valid Principal Dx

Valid for Submission

R75 is a billable code used to specify a medical diagnosis of inconclusive laboratory evidence of human immunodeficiency virus [hiv]. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code R75 might also be used to specify conditions or terms like false positive serology for human immunodeficiency virus antibody or finding of hiv status or human immunodeficiency virus p24 antigen positive or reactive for both human immunodeficiency virus antibodies and p24 antigen or serology: false positive.

According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.

ICD-10:R75
Short Description:Inconclusive laboratory evidence of human immunodef virus
Long Description:Inconclusive laboratory evidence of human immunodeficiency virus [HIV]

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code R75:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Nonconclusive HIV-test finding in infants

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • asymptomatic human immunodeficiency virus HIV infection status Z21
  • human immunodeficiency virus HIV disease B20

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R75 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • False positive serology for human immunodeficiency virus antibody
  • Finding of HIV status
  • Human immunodeficiency virus p24 antigen positive
  • Reactive for both human immunodeficiency virus antibodies and p24 antigen
  • Serology: false positive

Diagnostic Related Groups

The ICD-10 code R75 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 814 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC
  • 815 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC
  • 816 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC

Convert R75 to ICD-9

  • 795.71 - Nonspcf serlgc evdnc hiv (Approximate Flag)

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of blood, without diagnosis (R70-R79)
      • Inconclusive laboratory evidence of human immunodef virus (R75)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020